๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Levosimendan, a New Calcium-Sensitizing Inotrope for Heart Failure

โœ Scribed by Tien M. H. Ng

Book ID
115048911
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
158 KB
Volume
24
Category
Article
ISSN
0277-0008

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Haemodynamic interactions of a new calci
Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril
โœ S. Antila; L. Lehtonen; E.-P. Sandell; J. Eha; M. Heinpalu; I. Loogna; A. Mesike ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Springer ๐ŸŒ English โš– 746 KB

Objective: Levosimendan in a new inodilator drug that sensitises troponin C in heart muscle cells to calcium, thus improving contractility. In previous studies, a single 2 mg intravenous dose of levosimendan increased cardiac output (CO) in healthy volunteers by about 40% and decreased pulmonary cap

Calcium-sensitizing inotropic agents in
Calcium-sensitizing inotropic agents in the treatment of heart failure: A critical view
โœ Roger J. Hajjar; Judith K. Gwathmey ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer US ๐ŸŒ English โš– 477 KB

## Interventions that augment the contractile state of the heart are associated with, or caused by, alterations in Ca 2รท exchange in heart muscles. New inotropic agents have been developed that increase the sensitivity of the myofilaments to Ca 2+. To examine the effect of calcium-sensitizing agen